PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS UNDERGOING ERCP ARE AT INCREASED RISK FOR PANCREATITIS: RECTAL INDOMETHACIN SIGNIFICANTLY REDUCES THE RISK

被引：0
|
作者：
Thiruvengadam, Nikhil
Forde, Kimberly A.
Chandrasekhara, Vinay
Kochman, Michael L.
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
10.1016/S0016-5085(17)30597-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
292
引用
收藏
页码：S73 / S73
页数：1
相关论文
共 50 条
  • [1] Rectal Indomethacin Reduces Pancreatitis in Both High and Low-Risk Patients Undergoing ERCP
    Thiruvengadam, Nikhil
    Forde, Kimberly A.
    Ma, Gene K.
    Ahmad, Nuzhat A.
    Chandrasekhara, Vinay
    Ginsberg, Gregory G.
    Ho, Immanuel
    Jaffe, David L.
    Panganamamula, Kashyap
    Kochman, Michael L.
    GASTROENTEROLOGY, 2016, 150 (04) : S698 - S698
  • [2] Post ERCP Pancreatitis Prophylaxis- Indomethacin significantly reduces the Risk
    Martin, W. -R.
    GASTROENTEROLOGE, 2012, 7 (04): : 336 - 337
  • [3] Rectal Indomethacin Reduces Pancreatitis in Patients with Malignant Biliary Obstruction Undergoing ERCP
    Thiruvengadam, Nikhil
    Forde, Kimberly A.
    Ma, Gene K.
    Ahmad, Nuzhat A.
    Chandrasekhara, Vinay
    Ginsberg, Gregory G.
    Ho, Immanuel
    Jaffe, David L.
    Panganamamula, Kashyap
    Kochman, Michael L.
    GASTROENTEROLOGY, 2016, 150 (04) : S698 - S699
  • [4] Increased risk of cancer in patients with primary sclerosing cholangitis
    Aiva Lundberg Båve
    Annika Bergquist
    Matteo Bottai
    Anna Warnqvist
    Erik von Seth
    Caroline Nordenvall
    Hepatology International, 2021, 15 : 1174 - 1182
  • [5] Increased risk of cancer in patients with primary sclerosing cholangitis
    Bave, Aiva Lundberg
    Bergquist, Annika
    Bottai, Matteo
    Warnqvist, Anna
    von Seth, Erik
    Nordenvall, Caroline
    HEPATOLOGY INTERNATIONAL, 2021, 15 (05) : 1174 - 1182
  • [6] Risk factors for complications of ERCP in primary sclerosing cholangitis
    Ismail, S.
    Kylanpaa, L.
    Mustonen, H.
    Halttunen, J.
    Lindstrom, O.
    Jokelainen, K.
    Udd, M.
    Farkkila, M.
    ENDOSCOPY, 2012, 44 (12) : 1133 - 1138
  • [7] ERCP FOR PRIMARY SCLEROSING CHOLANGITIS (PSC) - AN ACCEPTABLE RISK
    VANDENHAZEL, SJ
    VANLEEUWEN, DJ
    HEPATOLOGY, 1995, 22 (04) : 9 - 9
  • [8] Endoscopy Indomethacin reduces Pancreatitis- Risk after ERCP
    Lichert, Frank
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2015, 140 (18) : 1340 - 1340
  • [9] RECTAL NSAIDS AND SELECTIVE PANCREATIC STENTING SIGNIFICANTLY REDUCES ACUTE PANCREATITIS IN NORMAL RISK ERCP
    Killian, M.
    Maxudor, S.
    Looby, M.
    O'Connor, D.
    Stack, W.
    GUT, 2017, 66 : A15 - A15
  • [10] Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis
    Bergquist, Annika
    Montgomery, Scott M.
    Bahmanyar, Shahram
    Olsson, Rolf
    Danielsson, Ake
    Lindgren, Stefan
    Prytz, Hanne
    Hultcrantz, Rolf
    Loof, Lars
    Sandberg-Gertzen, Hanna
    Almer, Sven
    Askling, Johan
    Ehlin, Anna
    Ekbom, Anders
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2008, 6 (08) : 939 - 943
12345